4 results
Approved WMOCompleted
The purpose of the study is to determine the PK profile of three different intranasal testosterone formulations.
Approved WMORecruiting
To determine the effect of lithium treatment (plasma levels between 0,4-0,8 mEq/liter) versus placebo - in addition to riluzole 2dd 50 mg - on reaching a clinical endpoint in patients with ALS.
Approved WMOCompleted
Validation of the Eleveld PKPD model, both the pharmacokinetic component (plasma concentrations) and the pharmacodynamic component (effect: bispectral index (BIS) and predicted effect-site concentrations).
Approved WMORecruiting
To investigate the efficacy and safety of drugs for patients with ALS.